Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 88

1.

Reduced FcRn-mediated transcytosis of IgG2 due to a missing Glycine in its lower hinge.

Stapleton NM, Brinkhaus M, Armour KL, Bentlage AEH, de Taeye SW, Temming AR, Mok JY, Brasser G, Maas M, van Esch WJE, Clark MR, Williamson LM, van der Schoot CE, Vidarsson G.

Sci Rep. 2019 May 14;9(1):7363. doi: 10.1038/s41598-019-40731-2.

2.

Disulfide Modified IgG1: An Investigation of Biophysical Profile and Clinically Relevant Fc Interactions.

Bahou C, Love EA, Leonard S, Spears RJ, Maruani A, Armour K, Baker JR, Chudasama V.

Bioconjug Chem. 2019 Apr 17;30(4):1048-1054. doi: 10.1021/acs.bioconjchem.9b00174. Epub 2019 Mar 18.

PMID:
30855134
3.

Climate constraint reflects forced signal.

Po-Chedley S, Proistosescu C, Armour KC, Santer BD.

Nature. 2018 Nov;563(7729):E6-E9. doi: 10.1038/s41586-018-0640-y. Epub 2018 Oct 31. No abstract available.

PMID:
30382205
4.

Psoriasis and infection. A clinical practice narrative.

Rademaker M, Agnew K, Anagnostou N, Andrews M, Armour K, Baker C, Foley P, Gebauer K, Gupta M, Marshman G, Rubel D, Sullivan J, Wong LC.

Australas J Dermatol. 2019 May;60(2):91-98. doi: 10.1111/ajd.12895. Epub 2018 Aug 5. Review.

PMID:
30079566
5.

Psoriasis and cancer. An Australian/New Zealand narrative.

Rademaker M, Rubel DM, Agnew K, Andrews M, Armour KS, Baker C, Foley P, Gebauer K, Goh MS, Gupta M, Marshman G, Prince HM, Sullivan J.

Australas J Dermatol. 2019 Feb;60(1):12-18. doi: 10.1111/ajd.12889. Epub 2018 Jul 10. Review.

PMID:
29992535
6.

Quantifying climate feedbacks in polar regions.

Goosse H, Kay JE, Armour KC, Bodas-Salcedo A, Chepfer H, Docquier D, Jonko A, Kushner PJ, Lecomte O, Massonnet F, Park HS, Pithan F, Svensson G, Vancoppenolle M.

Nat Commun. 2018 May 15;9(1):1919. doi: 10.1038/s41467-018-04173-0. Review.

7.

Adaptation, Acceptance and Adaptive Preferences in Health and Capability Well-Being Measurement Amongst Those Approaching End of Life.

Coast J, Bailey C, Orlando R, Armour K, Perry R, Jones L, Kinghorn P.

Patient. 2018 Oct;11(5):539-546. doi: 10.1007/s40271-018-0310-z.

PMID:
29744765
8.

Human IgG lacking effector functions demonstrate lower FcRn-binding and reduced transplacental transport.

Stapleton NM, Armstrong-Fisher SS, Andersen JT, van der Schoot CE, Porter C, Page KR, Falconer D, de Haas M, Williamson LM, Clark MR, Vidarsson G, Armour KL.

Mol Immunol. 2018 Mar;95:1-9. doi: 10.1016/j.molimm.2018.01.006. Epub 2018 Feb 20.

9.

Psoriasis in those planning a family, pregnant or breast-feeding. The Australasian Psoriasis Collaboration.

Rademaker M, Agnew K, Andrews M, Armour K, Baker C, Foley P, Frew J, Gebauer K, Gupta M, Kennedy D, Marshman G, Sullivan J.

Australas J Dermatol. 2018 May;59(2):86-100. doi: 10.1111/ajd.12641. Epub 2017 May 23. Review.

PMID:
28543445
10.

Comparison of self-reported signs of facial ageing among Caucasian women in Australia versus those in the USA, the UK and Canada.

Goodman GJ, Armour KS, Kolodziejczyk JK, Santangelo S, Gallagher CJ.

Australas J Dermatol. 2018 May;59(2):108-117. doi: 10.1111/ajd.12637. Epub 2017 Apr 10.

11.

A team approach to recruitment in hospice research: engaging patients, close people and health professionals.

L Campbell C, Bailey C, Armour K, Perry R, Orlando R, Kinghorn P, Jones L, Coast J.

Int J Palliat Nurs. 2016 Jul 2;22(7):324-32. doi: 10.12968/ijpn.2016.22.7.324.

PMID:
27444161
12.

The Australasian Psoriasis Collaboration view on methotrexate for psoriasis in the Australasian setting.

Rademaker M, Gupta M, Andrews M, Armour K, Baker C, Foley P, Gebauer K, George J, Rubel D, Sullivan J.

Australas J Dermatol. 2017 Aug;58(3):166-170. doi: 10.1111/ajd.12521. Epub 2016 Jul 12. Review.

PMID:
27402434
13.

Igg Subclasses Targeting the Flagella of Salmonella enterica Serovar Typhimurium Can Mediate Phagocytosis and Bacterial Killing.

Goh YS, Armour KL, Clark MR, Grant AJ, Mastroeni P.

J Vaccines Vaccin. 2016 May 30;7(3). pii: 322.

14.

Development of a Wearable Cardiac Monitoring System for Behavioral Neurocardiac Training: A Usability Study.

Uddin AA, Morita PP, Tallevi K, Armour K, Li J, Nolan RP, Cafazzo JA.

JMIR Mhealth Uhealth. 2016 Apr 22;4(2):e45. doi: 10.2196/mhealth.5288.

15.

Human IgG1 antibodies suppress angiogenesis in a target-independent manner.

Bogdanovich S, Kim Y, Mizutani T, Yasuma R, Tudisco L, Cicatiello V, Bastos-Carvalho A, Kerur N, Hirano Y, Baffi JZ, Tarallo V, Li S, Yasuma T, Arpitha P, Fowler BJ, Wright CB, Apicella I, Greco A, Brunetti A, Ruvo M, Sandomenico A, Nozaki M, Ijima R, Kaneko H, Ogura Y, Terasaki H, Ambati BK, Leusen JH, Langdon WY, Clark MR, Armour KL, Bruhns P, Verbeek JS, Gelfand BD, De Falco S, Ambati J.

Signal Transduct Target Ther. 2016;1. pii: 15001. Epub 2016 Jan 28.

16.

'The ICECAP-SCM tells you more about what I'm going through': A think-aloud study measuring quality of life among patients receiving supportive and palliative care.

Bailey C, Kinghorn P, Orlando R, Armour K, Perry R, Jones L, Coast J.

Palliat Med. 2016 Jul;30(7):642-52. doi: 10.1177/0269216315624890. Epub 2016 Jan 27.

17.

Comparison of informal caregiver and named nurse assessment of symptoms in elderly patients dying in hospital using the palliative outcome scale.

Dawber R, Armour K, Ferry P, Mukherjee B, Carter C, Meystre C.

BMJ Support Palliat Care. 2019 Jun;9(2):175-182. doi: 10.1136/bmjspcare-2015-000850. Epub 2016 Jan 12.

18.

PA22 The arts of connexion.

Brooks J, Maher R, Armour K, Jarrett L.

BMJ Support Palliat Care. 2015 Apr;5 Suppl 1:A26. doi: 10.1136/bmjspcare-2015-000906.82.

PMID:
25960508
19.

PA14 The legacy of cancer: why a health promoting approach is so important in palliative care.

Baker N, Armour K, Meystre C, Redwood S, Dawson A.

BMJ Support Palliat Care. 2015 Apr;5 Suppl 1:A23-4. doi: 10.1136/bmjspcare-2015-000906.74.

PMID:
25960500
20.

PA2 Satisfaction with information received: perceptions of the patient and the informal caregiver.

Dawber R, Armour K, Carter C, Ferry P, Meystre C.

BMJ Support Palliat Care. 2015 Apr;5 Suppl 1:A20. doi: 10.1136/bmjspcare-2015-000906.62.

PMID:
25960488
21.

Shortwave and longwave radiative contributions to global warming under increasing CO2.

Donohoe A, Armour KC, Pendergrass AG, Battisti DS.

Proc Natl Acad Sci U S A. 2014 Nov 25;111(47):16700-5. doi: 10.1073/pnas.1412190111. Epub 2014 Nov 10.

22.

Clearance of human IgG1-sensitised red blood cells in vivo in humans relates to the in vitro properties of antibodies from alternative cell lines.

Armour KL, Smith CS, Ip NC, Ellison CJ, Kirton CM, Wilkes AM, Williamson LM, Clark MR.

PLoS One. 2014 Oct 10;9(10):e109463. doi: 10.1371/journal.pone.0109463. eCollection 2014.

23.

The ocean's role in polar climate change: asymmetric Arctic and Antarctic responses to greenhouse gas and ozone forcing.

Marshall J, Armour KC, Scott JR, Kostov Y, Hausmann U, Ferreira D, Shepherd TG, Bitz CM.

Philos Trans A Math Phys Eng Sci. 2014 Jul 13;372(2019):20130040. doi: 10.1098/rsta.2013.0040.

24.

Hypertriglyceridaemia with acitretin use: a proposal for its management in the context of overall cardiovascular risk.

Chan BC, Reid N, Armour K, Scott RS, George PM, Maurice PD.

Br J Dermatol. 2014 Sep;171(3):665-7. doi: 10.1111/bjd.13027. Epub 2014 Jul 26. No abstract available.

PMID:
24697159
25.

An investigation into IgE-facilitated allergen recognition and presentation by human dendritic cells.

Sharquie IK, Al-Ghouleh A, Fitton P, Clark MR, Armour KL, Sewell HF, Shakib F, Ghaemmaghami AM.

BMC Immunol. 2013 Dec 13;14:54. doi: 10.1186/1471-2172-14-54.

26.

Low-affinity FcγR interactions can decide the fate of novel human IgG-sensitised red blood cells and platelets.

Armour KL, Smith CS, Turner CP, Kirton CM, Wilkes AM, Hadley AG, Ghevaert C, Williamson LM, Clark MR.

Eur J Immunol. 2014 Mar;44(3):905-14. doi: 10.1002/eji.201343825. Epub 2014 Feb 16.

27.

Fc gamma receptor 3A polymorphism and risk for HIV-associated cryptococcal disease.

Rohatgi S, Gohil S, Kuniholm MH, Schultz H, Dufaud C, Armour KL, Badri S, Mailliard RB, Pirofski LA.

MBio. 2013 Aug 27;4(5):e00573-13. doi: 10.1128/mBio.00573-13.

28.

Recombinant HPA-1a antibody therapy for treatment of fetomaternal alloimmune thrombocytopenia: proof of principle in human volunteers.

Ghevaert C, Herbert N, Hawkins L, Grehan N, Cookson P, Garner SF, Crisp-Hihn A, Lloyd-Evans P, Evans A, Balan K, Ouwehand WH, Armour KL, Clark MR, Williamson LM.

Blood. 2013 Jul 18;122(3):313-20. doi: 10.1182/blood-2013-02-481887. Epub 2013 May 8.

29.

An overview of surrogacy around the world: trends, questions and ethical issues.

Armour KL.

Nurs Womens Health. 2012 Jun-Jul;16(3):231-6. doi: 10.1111/j.1751-486X.2012.01734.x. Review.

PMID:
22697226
30.

Biopharmaceuticals and biosimilars in psoriasis: what the dermatologist needs to know.

Strober BE, Armour K, Romiti R, Smith C, Tebbey PW, Menter A, Leonardi C.

J Am Acad Dermatol. 2012 Feb;66(2):317-22. doi: 10.1016/j.jaad.2011.08.034. Review.

PMID:
22243723
31.

Human IgG isotypes and activating Fcγ receptors in the interaction of Salmonella enterica serovar Typhimurium with phagocytic cells.

Goh YS, Grant AJ, Restif O, McKinley TJ, Armour KL, Clark MR, Mastroeni P.

Immunology. 2011 May;133(1):74-83. doi: 10.1111/j.1365-2567.2011.03411.x. Epub 2011 Feb 16.

32.

Expression of human FcgammaRIIIa as a GPI-linked molecule on CHO cells to enable measurement of human IgG binding.

Armour KL, Smith CS, Clark MR.

J Immunol Methods. 2010 Mar 31;354(1-2):20-33. doi: 10.1016/j.jim.2010.01.011. Epub 2010 Feb 4.

PMID:
20138184
33.

Maternal mortality here and abroad: awareness, advocacy and action.

Armour KL.

Nurs Womens Health. 2009 Jun;13(3):187-90. doi: 10.1111/j.1751-486X.2009.01417.x. No abstract available.

PMID:
19523130
34.

Ultrasound therapy for lipodermatosclerosis.

Damian DL, Yiasemides E, Gupta S, Armour K.

Arch Dermatol. 2009 Mar;145(3):330-2. doi: 10.1001/archdermatol.2009.24. No abstract available.

PMID:
19289773
35.

Developing recombinant HPA-1a-specific antibodies with abrogated Fcgamma receptor binding for the treatment of fetomaternal alloimmune thrombocytopenia.

Ghevaert C, Wilcox DA, Fang J, Armour KL, Clark MR, Ouwehand WH, Williamson LM.

J Clin Invest. 2008 Aug;118(8):2929-38. doi: 10.1172/JCI34708.

36.

An immunoglobulin E-reactive chimeric human immunoglobulin G1 anti-idiotype inhibits basophil degranulation through cross-linking of FcepsilonRI with FcgammaRIIb.

Wigginton SJ, Furtado PB, Armour KL, Clark MR, Robins A, Emara M, Ghaemmaghami AM, Sewell HF, Shakib F.

Clin Exp Allergy. 2008 Feb;38(2):313-9. Epub 2007 Dec 7.

PMID:
18070161
37.

Here's looking at you... Picture archiving in medical records.

Armour KL.

Biomed Instrum Technol. 2007;Suppl:48-50. No abstract available.

PMID:
17929654
38.

Treatment of palmoplantar warts with a diphencyprone and salicylic acid ointment.

Armour K, Orchard D.

Australas J Dermatol. 2006 Aug;47(3):182-5.

PMID:
16866999
39.

Specificity of the trypanothione-dependent Leishmania major glyoxalase I: structure and biochemical comparison with the human enzyme.

Ariza A, Vickers TJ, Greig N, Armour KA, Dixon MJ, Eggleston IM, Fairlamb AH, Bond CS.

Mol Microbiol. 2006 Feb;59(4):1239-48.

40.

Intravascular survival of red cells coated with a mutated human anti-D antibody engineered to lack destructive activity.

Armour KL, Parry-Jones DR, Beharry N, Ballinger JR, Mushens R, Williams RK, Beatty C, Stanworth S, Lloyd-Evans P, Scott M, Clark MR, Peters AM, Williamson LM.

Blood. 2006 Apr 1;107(7):2619-26. Epub 2005 Dec 1.

PMID:
16322478
41.

Function-blocking antibodies to human vascular adhesion protein-1: a potential anti-inflammatory therapy.

Kirton CM, Laukkanen ML, Nieminen A, Merinen M, Stolen CM, Armour K, Smith DJ, Salmi M, Jalkanen S, Clark MR.

Eur J Immunol. 2005 Nov;35(11):3119-30.

42.

Borderline lepromatous leprosy presenting as a single cutaneous plaque.

Armour KS, Scolyer RA, Barnetson RS.

Australas J Dermatol. 2005 Aug;46(3):181-3.

PMID:
16008652
43.

Prevention of triplets and higher order multiples: trends in reproductive medicine.

Armour KL, Callister LC.

J Perinat Neonatal Nurs. 2005 Apr-Jun;19(2):103-11. Review.

PMID:
15923959
45.

A chimeric antibody to varicella-zoster virus glycoprotein e.

Shankar V, Kools JJ, Armour KL, Clark MR.

Hybridoma (Larchmt). 2005 Feb;24(1):50-4.

PMID:
15785209
46.

Complicated lichenoid drug eruption.

Armour K, Lowe P.

Australas J Dermatol. 2005 Feb;46(1):21-4.

PMID:
15670173
47.

Should three-dimensional fetal imaging be used for nondiagnostic portraits?

Armour KL.

MCN Am J Matern Child Nurs. 2005 Jan-Feb;30(1):9. No abstract available.

PMID:
15622139
48.

PDAs in nursing. Here's why & how to use this emerging clinical tool.

Armour K.

AWHONN Lifelines. 2004 Jun-Jul;8(3):241-7. Review. No abstract available.

PMID:
15305598
49.

Antepartum maternal-fetal assessment. Using surveillance to improve maternal and fetal outcomes.

Armour K.

AWHONN Lifelines. 2004 Jun-Jul;8(3):232-40. Review. No abstract available.

PMID:
15305597
50.

The effect of recombinant IgG antibodies against the leucine-33 form of the platelet beta3 integrin (HPA-1a) on platelet function.

Joutsi-Korhonen L, Preston S, Smethurst PA, Ijsseldijk M, Schaffner-Reckinger E, Armour KL, Watkins NA, Clark MR, de Groot PG, Farndale RW, Ouwehand WH, Williamson LM.

Thromb Haemost. 2004 Apr;91(4):743-54.

PMID:
15045136

Supplemental Content

Loading ...
Support Center